Endocrinology CME Center | Endocrine Today

Welcome, Guest

Endocrine Today Home

Upcoming Live Events

Endocrinology CME Activities

Show: All Journal Monograph Multimedia


	First Annual Scripps Health Cardiometabolic Summit: Determining the Link Between Diabetes, Obesity, and Cardiovascular Disease
	Author(s)/Faculty: Ken Fujioka, MD; Michael W. Lee, MD; James R. Gavin, III, MD, PhD; Mark C. Takata, MD; more Douglas W. Triffon, MD
	Source: Endocrine Today	Type: Multimedia	Number of Articles: 1
	Release Date: September 2010	Expiration Date: September 30, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 2.25	Provider:
	OVERVIEW Obesity is a major contributor to diabetes and cardiovascular disease and, despite a variety of available treatments and surgical options, these health problems have reached epidemic proportions in the United States. This activity will serve as an educational intervention to increase physicians’ awareness of strategies to reduce the burden of obesity, diabetes, and cardiovascular disease. The history, pathophysiology, and genetics of obesity will be reviewed. Lifestyle changes that can lead to weight reduction, such as diet, exercise, and behavioral modification, will be presented. Leading clinicians will also discuss therapeutic interventions and surgical options for diabetes, obesity, and their comorbidities.


	Glycemic Control and Blood Pressure Control in the Management of Type 2 Diabetes – Podcast Series 6
	Author(s)/Faculty: Jay Shubrook, DO, FACOFP; Suma Dronavalli, MD; William J. Elliott, MD, PhD more Jay Shubrook, DO, FACOFP; Suma Dronavalli, MD; William J. Elliott, MD, PhD
	Source: Endocrine Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.75	Provider:
	OVERVIEW Diabetes and Cardiovascular risk factors


	Optimizing Glycemic Control and Cardiovascular Risk Reduction: A Guidelines-Based Approach – Podcast Series 5
	Author(s)/Faculty: Jeffrey Freeman, DO; Frank Lavernia, MD; Carol H. Wysham, MD more Jeffrey Freeman, DO; Frank Lavernia, MD; Carol H. Wysham, MD
	Source: Endocrine Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.75	Provider:
	OVERVIEW Diabetes and Cardiovascular risk factors


	Minimizing CVD Risk and Complications in the Treatment of Patients with Type 2 Diabetes– Podcast Series 4
	Author(s)/Faculty: Tara Lynn Dall, MD; Steven Jones, MD, FACC, ABCL; Matthew R. Weir, M.D. more Tara Lynn Dall, MD; Steven Jones, MD, FACC, ABCL; Matthew R. Weir, M.D.
	Source: Endocrine Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.75	Provider:
	OVERVIEW Lipid and Diabetes and cardiovascular risks.


	The Role of Incretin-base Therapies in Treating Type 2 Diabetes – Podcast Series 3
	Author(s)/Faculty: George L. Bakris, MD, FAHA, FASN; Mark Stolar, MD; Frank Svec, MD, PhD more George L. Bakris, MD, FAHA, FASN; Mark Stolar, MD; Frank Svec, MD, PhD
	Source: Endocrine Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.50	Provider:
	OVERVIEW Diabetic Kidney Disease


	Recognition, Diagnosis, and Management of Pre-diabetes and New-onset Type 2 Diabetes – Podcast Series 2
	Author(s)/Faculty: Ronald A. Codario, MD, FACP; Anne L. Peters, MD, FACP, CDE; Louis H. Philipson, MD, PhD more Ronald A. Codario, MD, FACP; Anne L. Peters, MD, FACP, CDE; Louis H. Philipson, MD, PhD
	Source: Endocrine Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.75	Provider:
	OVERVIEW Management of Diabetes


	Managing Dyslipidemia, Hypertension, and Cardiovascular Risk Factors in Patients with Diabetes – Podcast Series 1
	Author(s)/Faculty: Michael H. Davidson, MD, FACC, FACP;Tom Dayspring, MD;Matthew Sorrentino, MD, FACC more Michael H. Davidson, MD, FACC, FACP;Tom Dayspring, MD;Matthew Sorrentino, MD, FACC
	Source: Endocrine Today	Type: Multimedia	Number of Articles: 3
	Release Date: August 2010	Expiration Date: August 16, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 0.75	Provider:
	OVERVIEW Managing dyslipidemia and hypertension


	Emerging Therapeutics in Type 2 Diabetes: Interpreting the Science
	Author(s)/Faculty: George L. Bakris, MD, FASH, FASN; Lawrence Blonde, MD, FACP, FACE; James R. Gavin III, more MD, PhD; Scott V. Joy, MD, FACP; and Carol H. Wysham, MD
	Source: Endocrine Today	Type: Monograph	Number of Articles: 1
	Release Date: August 2010	Expiration Date: August 31, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 1.75	Provider:
	OVERVIEW The increasing prevalence of type 2 diabetes is highly concerning. Knowledge of the risks and benefits of available therapies is crucial to reducing this disease burden. This monograph represents an analysis of clinical trials presented during the American Diabetes Association 70th Scientific Sessions. The association of type 2 diabetes with cardiovascular risk is evaluated, as well as the effects of various diabetes therapies on cardiovascular outcomes. The efficacy and safety profiles of emerging therapies, such as glucagon-like peptide-1 mimetics and sodium glucose co-transporter 2 inhibitors, are presented along with data regarding their effects on cardiovascular risk factors. Leading clinicians will also interpret the results of the DURATION trials, in which the efficacy and safety of exenatide was compared to insulin glargine, pioglitazone, and sitagliptin. The success of a community-based lifestyle intervention program is discussed, along with methods to implement such a program. These are only a few examples of the variety of studies that are analyzed in this monograph.

1
2
3